Price Alert

ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · Real-Time Price · USD

4.49

0.05 (1.13%)

At close: Aug 15, 2025, 11:51 AM

ENDRA Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	2.06M	3.23M	4.75M	6.4M	1.13M	2.83M	3.33M	4.82M	2.36M	4.89M	8.02M	11.28M	7.13M	9.46M	11.79M	14.04M	16.84M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	371.4K	371.4K	3.11M	3.36M	3.36M	3.26M	650.6K	536.05K	438.33K	5.99K	5.99K	5.99K	5.99K	5.99K	5.99K	0.00	0.00
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	-305.88K	-506.91K	-428.53K	n/a	-914.26K	-834.86K	-1.06M	-1.35M	-1.18M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	2.71M	2.62M	2.76M	2.76M	2.74M	2.64M	2.63M	2.37M	1.93M	1.28M	1.5M	1.32M	726.61K
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	305.88K	506.91K	428.53K	n/a	914.26K	834.86K	1.06M	1.35M	1.18M	5.99K	5.99K
Total Current Assets	2.18M	3.43M	4.96M	6.71M	1.27M	3.03M	6.4M	8.08M	5.52M	8.53M	11.56M	14.49M	10.12M	12.09M	14.47M	16.34M	18.35M
Property-Plant & Equipment	618.99K	647.29K	310.05K	364.06K	425.19K	465.87K	554.27K	624.72K	697.43K	741.47K	772.07K	815.8K	811.68K	774.54K	838.09K	899.59K	547.38K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	990.39K	1.02M	3.42M	3.73M	3.79M	3.72M	1.2M	1.16M	1.14M	747.46K	778.05K	821.78K	817.66K	780.53K	844.07K	899.59K	547.38K
Total Assets	3.17M	4.45M	8.38M	10.44M	5.06M	6.75M	7.6M	9.24M	6.65M	9.27M	12.34M	15.31M	10.94M	12.87M	15.31M	17.24M	18.9M
Account Payables	223.59K	269.68K	279.42K	300.36K	521.58K	360.4K	419.14K	414.94K	524.03K	613.96K	636.7K	785.07K	833.86K	791.05K	747.76K	807.11K	447.95K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-447.63K	-443.42K	n/a	n/a	n/a	n/a	n/a	-791.05K	n/a	n/a	n/a
Short-Term Debt	n/a	96.94K	208.18K	182.73K	178.24K	28.48K	28.48K	28.48K	28.48K	28.48K	147.06K	142.03K	137.12K	132.33K	127.7K	123.19K	79.17K
Other Current Liabilities	n/a	5.75K	0.00	90.36K	-18.37K	148.79K	214.65K	290.62K	821.54K	158.93K	375.89K	213.81K	69.27K	269.46K	172.61K	169.65K	25.31K
Total Current Liabilities	565.78K	605.23K	814.04K	1.35M	1.22M	903.1K	2.17M	2.03M	1.83M	1.7M	1.71M	1.5M	1.36M	1.54M	1.58M	1.64M	765.83K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	237.16K	n/a	n/a	n/a	28.48K	28.48K	28.48K	28.48K	28.48K	28.48K	28.48K
Other Long-Term Liabilities	390.72K	799.28K	910.56K	n/a	n/a	n/a	-237.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	851.93K	1.29M	960.38K	98.42K	145.82K	192.06K	237.16K	281.15K	324.06K	365.92K	434.26K	472.65K	510.1K	546.63K	581.31K	614.68K	280.83K
Total Liabilities	1.42M	1.89M	1.77M	1.45M	1.36M	1.1M	2.41M	2.31M	2.16M	2.07M	2.14M	1.98M	1.87M	2.09M	2.16M	2.25M	1.05M
Total Debt	587.3K	584.42K	237.16K	281.15K	324.06K	394.4K	434.26K	472.65K	510.1K	546.63K	581.31K	614.68K	647.22K	678.96K	709.01K	737.87K	360K
Common Stock	55.00	53.00	53.00	7.24K	1.09K	1.04K	841.00	748.00	317.00	317.00	6.32K	6.32K	4.45K	4.25K	4.21K	4.18K	4.16K
Retained Earnings	-104.47M	-103.44M	-99.29M	-96.94M	-94.71M	-91.93M	-90.47M	-87.37M	-84.81M	-81.87M	-78.58M	-75.14M	-71.55M	-68.69M	-65.59M	-62.93M	-59.73M
Comprehensive Income	n/a	n/a	n/a	27.00	301.00	5.23K	n/a	n/a	3.69K	6.07K	8.49K	5.81K	8.77K	n/a	42.66K	74.91K	-617.29K
Shareholders Equity	1.75M	2.56M	6.6M	8.99M	3.7M	5.66M	5.2M	6.93M	4.5M	7.2M	10.2M	13.33M	9.07M	10.78M	13.16M	14.99M	17.85M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a